TABLE 2.
Male |
Female |
|||||||
---|---|---|---|---|---|---|---|---|
Count | Rate‡ | 95% CI | RR | Count | Rate | 95% CI | RR | |
Total | 6497 | 1.00 | 0.98–1.03 | 11,608 | 1.51 | 1.48–1.54 | ||
Age, y | ||||||||
<50 | 2185 | 0.44 | 0.42–0.45 | 1.00 | 2531 | 0.50 | 0.48–0.52 | 1.00 |
50–64 | 2098 | 2.03 | 1.95–2.12 | 4.66§ | 3823 | 3.46 | 3.35–3.57 | 6.97§ |
≥65 | 2214 | 3.01 | 2.88–3.14 | 6.90§ | 5254 | 5.01 | 4.88–5.15 | 10.09§ |
Race | ||||||||
White | 5559 | 0.99 | 0.96–1.01 | 1.00 | 10,436 | 1.58 | 1.54–1.61 | 1.00 |
Black | 743 | 1.21 | 1.12–1.31 | 1.23§ | 911 | 1.28 | 1.20–1.37 | 0.81§ |
API | 45 | 0.20 | 0.14–0.27 | 0.20§ | 112 | 0.43 | 0.36–0.52 | 0.28§ |
Ethnicity | ||||||||
Non-Hispanic | 6067 | 1.02 | 1.00–1.05 | 1.00 | 10,777 | 1.53 | 1.50–1.56 | 1.00 |
Hispanic‖ | 430 | 0.78 | 0.70–0.86 | 0.76§ | 831 | 1.50 | 1.40–1.61 | 0.98 |
Region | ||||||||
Northeast | 1545 | 1.03 | 0.98–1.08 | 1.00 | 2543 | 1.38 | 1.33–1.44 | 1.00 |
Midwest | 1438 | 0.82 | 0.78–0.86 | 0.80§ | 2886 | 1.39 | 1.34–1.44 | 1.01 |
South | 1907 | 1.08 | 1.03–1.13 | 1.05 | 3588 | 1.72 | 1.66–1.77 | 1.24§ |
West | 1607 | 1.10 | 1.05–1.16 | 1.07 | 2591 | 1.57 | 1.51–1.63 | 1.14§ |
95% CI indicates 95% confidence interval; RR, rate ratio; API, Asian/Pacific Islander.
Includes squamous cell carcinoma of the anus, anal canal, and rectum and the squamous cell variants classified as transitional cell, basaloid, and cloacogenic.
Data are from 39 population-based cancer registries that participate in the National Program of Cancer Registries and/or the National Cancer Institute’s Surveillance, Epidemiology, and End Results program and meet the high-quality data criteria.10 These registries cover 83% of the US population.
Rates are per 100,000 population and are age-adjusted to the 2000 US standard population (19 age groups, Census P25-1130).
Significant at P ≤.05.
Hispanic origin is not mutually exclusive of race categories (white, black, API).